Utilization of Short-Acting Hormonal Contraceptives in Premenopausal Women

Overview

This study analyzes trends in the use of short-acting hormonal contraceptives among premenopausal women in the U.S. from 1999 to 2020, utilizing data from the National Health and Nutrition Examination Survey (NHANES).

Background

Hormonal contraceptives play a role in reproductive health, providing benefits such as managing menstrual disorders. Understanding their utilization trends is essential for public health strategies aimed at improving access to contraceptive options.

Data Highlights

Key Findings

• Current contraceptive use among U.S. females aged 15 to 49 years remained stable at 64% to 65% from 2015 to 2019.
• Short-acting hormonal contraceptives, including oral contraceptive pills, injections, and patches, are among the most commonly used methods.
• There has been a modest decrease in the use of combined estrogen-progestin oral contraceptive pills.
• Long-acting reversible contraceptives have seen increased adoption over the years.
• The study utilized data from the National Health and Nutrition Examination Survey (NHANES) to analyze trends among premenopausal women.

Clinical Implications

Clinicians should be aware of the stable trends in hormonal contraceptive use and the increasing preference for long-acting methods. This knowledge can guide discussions with patients regarding contraceptive options and their associated benefits and risks.

Conclusion

The analysis of NHANES data provides insights into the utilization patterns of short-acting hormonal contraceptives among premenopausal women.

Related Resources & Content

1. Frontiers in Psychiatry, 2026 -- Identifying psychiatric comorbidities that occur following the introduction of hormonal contraception: a scoping review
2. The ASCO Post, November 2025 -- Study Finds Breast Cancer Risk Varies Between Different Hormonal Contraceptives
3. JAMA Network Open -- Three-Year Contraceptive Failure Rates During the HER Salt Lake Contraceptive Initiative
4. JAMA Network Open -- Optimizing Contraceptive Effectiveness—Lessons From HER Salt Lake on Prioritizing Patient-Centered Care
5. Executive summary - Selected practice recommendations for contraceptive use - NCBI Bookshelf
6. Oral contraceptives exposure may reduce the risk of ovarian cancer: a meta-analysis based on cohort studies - PMC
7. Current guidance anchors
8. Oral contraceptives exposure may reduce the risk of ovarian cancer: a meta-analysis based on cohort studies - PMC
9. One year of Opill: Retail sales of over-the-counter birth control pills in the United States - ScienceDirect